0001127602-19-002527.txt : 20190123
0001127602-19-002527.hdr.sgml : 20190123
20190123161220
ACCESSION NUMBER: 0001127602-19-002527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190118
FILED AS OF DATE: 20190123
DATE AS OF CHANGE: 20190123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Lynne
CENTRAL INDEX KEY: 0001631667
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 19537541
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-01-18
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001631667
Powell Lynne
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP - CCO
Common Stock
2019-01-18
4
M
0
2000
3.22
A
2000
D
Common Stock
2019-01-18
4
S
0
2000
9.40
D
0
D
Emp. Stock Option (Right to Buy)
3.22
2019-01-18
4
M
0
2000
0
D
2017-05-23
2026-05-23
Common Stock
2000
91427
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2018.
/s/ Alane P. Barnes, by power of attorney
2019-01-23